Efficacy of lactulose in cirrhotic patients with subclinical hepatic encephalopathy

被引:115
作者
Dhiman, RK [1 ]
Sawhney, IMS
Chawla, YK
Das, G
Ram, S
Dilawari, JB
机构
[1] Postgrad Inst Med Educ & Res, Dept Hepatol, Chandigarh 160012, India
[2] Postgrad Inst Med Educ & Res, Dept Neurol, Chandigarh 160012, India
关键词
lactulose; cirrhosis; encephalopathy; subclinical hepatic encephalopathy;
D O I
10.1023/A:1005556826152
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
To investigate the role of lactulose in the treatment of cirrhotic patients with subclinical hepatic encephalopathy (SHE), 40 cirrhotic patients, 33 males and 7 females, were included in the study. The diagnosis of SHE was made by quantitative psychometric tests including the number connection test (NCT), figure connection test (FCT) parts A and B, and two performance subtests of Wechsler adult intelligence scale, ie, picture completion (PC) and block design (BD) tests. SHE was diagnosed in 26 (65%) of 40 patients. Of these 26 patients, 14 patients were randomized to treatment group (lactulose 30-60 ml/day for three months, SHE-L) and 12 patients to no treatment group (no lactulose, SHE-NL). Psychometric tests were repeated in all patients in both groups and in six patients with no SHE (group NSHE, N = 14) after three months. The mean scores and number of the abnormal psychometric tests at entry were significantly higher in patients in groups SHE-L and SHE-NL than in patients in group NSHE; however, there was no significant difference between SHE-L and SHE-NL. The mean number of the abnormal psychometric tests decreased in patients in group SHE-L after three months of treatment with lactulose (2.9 +/- 0.9 vs 0.8 +/- 1.2; P = 0.004); however, there was no change in patients in group SHE-NL after three months (3.7 +/- 1.5 vs 3.5 +/-: 1.3; P = NS). While SHE improved in 8 of 10 patients in group SHE-L, none of the patients in group SHE-NL improved after three months of follow-up (P < 0.001). Two patients in group SHE-NL also developed overt encephalopathy during the study period. We conclude that lactulose treatment in cirrhotic patients with SHE is effective.
引用
收藏
页码:1549 / 1552
页数:4
相关论文
共 19 条
[1]  
CONN HO, 1977, GASTROENTEROLOGY, V72, P573
[2]  
DAS A, 1995, GASTROENTEROLOGY, V108, pA1057
[3]   EFFECT OF DIETARY-PROTEIN MANIPULATIONS IN SUBCLINICAL PORTAL-SYSTEMIC ENCEPHALOPATHY [J].
DEBRUIJN, KM ;
BLENDIS, LM ;
ZILM, DH ;
CARLEN, PL ;
ANDERSON, GH .
GUT, 1983, 24 (01) :53-60
[4]   FIGURE CONNECTION TEST - A UNIVERSAL TEST FOR ASSESSMENT OF MENTAL STATE [J].
DHIMAN, RK ;
SARASWAT, VA ;
VERMA, M ;
NAIK, SR .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1995, 10 (01) :14-23
[5]   BRANCHED-CHAIN AMINO-ACIDS IN THE TREATMENT OF LATENT PORTOSYSTEMIC ENCEPHALOPATHY - A DOUBLE-BLIND PLACEBO-CONTROLLED CROSSOVER STUDY [J].
EGBERTS, EH ;
SCHOMERUS, H ;
HAMSTER, W ;
JURGENS, P .
GASTROENTEROLOGY, 1985, 88 (04) :887-895
[6]   THE DIAGNOSIS AND PREVALENCE OF SUBCLINICAL HEPATIC-ENCEPHALOPATHY IN APPARENTLY HEALTHY, AMBULANT, NON-SHUNTED PATIENTS WITH CIRRHOSIS [J].
GITLIN, N ;
LEWIS, DC ;
HINKLEY, L .
JOURNAL OF HEPATOLOGY, 1986, 3 (01) :75-82
[7]  
GITLIN N, 1988, AM J GASTROENTEROL, V82, P8
[8]  
KARDEL T, 1970, Scandinavian Journal of Gastroenterology, V5, P681
[9]  
MCCLAIN CJ, 1984, J CLIN GASTROENTEROL, V6, P325
[10]   LACTITOL AND LACTULOSE FOR THE TREATMENT OF SUBCLINICAL HEPATIC-ENCEPHALOPATHY IN CIRRHOTIC-PATIENTS - A RANDOMIZED, CROSSOVER STUDY [J].
MORGAN, MY ;
ALONSO, M ;
STANGER, LC .
JOURNAL OF HEPATOLOGY, 1989, 8 (02) :208-217